...
首页> 外文期刊>Bioorganic and medicinal chemistry >Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitors.
【24h】

Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitors.

机译:二取代的吡啶基氨基羟基苯磺酸盐作为有效的和高度选择性的人β-分泌酶(Bace1)抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

The identification of highly selective small molecule di-substituted pyridinyl aminohydantoins as beta-secretase inhibitors is reported. The more potent and selective analogs demonstrate low nanomolar potency for the BACE1 enzyme as measured in a FRET assay, and exhibit comparable activity in a cell-based (ELISA) assay. In addition, these pyridine-aminohydantoins are highly selectivity (>500x) against the other structurally related aspartyl proteases BACE2, cathepsin D, pepsin and renin. Our design strategy followed a traditional SAR approach and was supported by molecular modeling studies based on the previously reported aminohydantoin 3a. We have taken advantage of the amino acid difference between the BACE1 and BACE2 at the S2' pocket (BACE1 Pro(70) changed to BACE2 Lys(86)) to build ligands with >500-fold selectivity against BACE2. The addition of large substituents on the targeted ligand at the vicinity of this aberration has generated a steric conflict between the ligand and these two proteins, thus impacting the ligand's affinity and selectivity. These ligands have also shown an exceptional selectivity against cathepsin D (>5000-fold) as well as the other aspartyl proteases mentioned. One of the more potent compounds (S)-39 displayed an IC(50) value for BACE1 of 10nM, and exhibited cellular activity with an EC(50) value of 130nM in the ELISA assay.
机译:报道了作为β分泌酶抑制剂的高选择性小分子二取代吡啶基氨基硫氨酸的鉴定。更有效和选择性的类似物表明了在FRET测定中测量的BACE1酶的低纳摩效力,并在细胞基(ELISA)测定中表现出可比活性。此外,这些吡啶 - 氨基羟基磺酸丁蛋白对另一个结构相关的阿氨酰蛋白酶Bace2,组织蛋白酶D,胃蛋白酶和肾素具有高度选择性(> 500倍)。我们的设计策略遵循传统的SAR方法,并基于先前报道的氨基羟丁蛋白3A的分子建模研究支持。我们已经利用了S2'袋的BACE1和BACE2之间的氨基酸差(Bace1 Pro(70)改变为Bace2 Lys(86))以构建具有> 500倍的选择性对Bace2的配体。在该像差附近的靶向配体上加入大取代基在配体和这两种蛋白质之间产生了空间突出,从而影响了配体的亲和力和选择性。这些配体还显示出针对组织蛋白酶D(> 5000倍)的特殊选择性以及所提及的其它阿斯巴氨酸蛋白酶。展示了10nm的10nm的IC(50)值的一种越高的化合物(50)值,并在ELISA测定中表现出具有130nm的EC(50)值的细胞活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号